Bioengineered human colon organoids with in vivo-like cellular complexity and function
Cell Stem Cell · 2024-08 · 31 (8) · 1175-1186.e7
DOI: 10.1016/j.stem.2024.05.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2024-08. Verfasst von Olga Mitrofanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel 4052, Switzerland. Hauptthemen laut MEDLINE: Organoids, Colon, Bioengineering, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: École Polytechnique Fédérale de Lausanne, Roche, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Organoids and organs-on-a-chip have emerged as powerful tools for modeling human gut physiology and disease in vitro. Although physiologically relevant, these systems often lack the environmental milieu, spatial organization, cell type diversity, and maturity necessary for mimicking human intestinal mucosa. To instead generate models closely resembling in vivo tissue, we herein integrated organoid and organ-on-a-chip technology to develop an advanced human organoid model, called "mini-colons." By employing an asymmetric stimulation with growth factors, we greatly enhanced tissue longevity and replicated in vivo-like diversity and patterning of proliferative and differentiated cell types. Mini-colons contain abundant mucus-producing goblet cells and, signifying mini-colon maturation, single-cell RNA sequencing reveals emerging mature and functional colonocytes. This methodology is expanded to generate microtissues from the small intestine and incorporate additional microenvironmental components. Finally, our bioengineered organoids provide a precise platform to systematically study human gut physiology and pathology, and a reliable preclinical model for drug safety assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel 4052, Switzerland.
- Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne 1015, Switzerland.
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel 4052, Switzerland.
- Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel 4052, Switzerland; Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, Ecole Polytechn…
Förderung
- École Polytechnique Fédérale de Lausanne
- Roche
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Hutchinson Community Foundation
- F. Hoffmann-La Roche
- Horizon 2020
Zitieren
APA
Mitrofanova, O., Nikolaev, M., Xu, Q., Broguiere, N., Cubela, I., Camp, J. G., Bscheider, M., & Lutolf, M. P. (2024). Bioengineered human colon organoids with in vivo-like cellular complexity and function. Cell Stem Cell, 31(8), 1175-1186.e7. https://doi.org/10.1016/j.stem.2024.05.007
Vancouver
Mitrofanova O, Nikolaev M, Xu Q, Broguiere N, Cubela I, Camp JG, et al. Bioengineered human colon organoids with in vivo-like cellular complexity and function. Cell Stem Cell. 2024;31(8):1175-1186.e7. doi:10.1016/j.stem.2024.05.007
BibTeX
@article{Mitrofanova2024,
author = {Mitrofanova, Olga and Nikolaev, Mikhail and Xu, Quan and Broguiere, Nicolas and Cubela, Irineja and Camp, J Gray and Bscheider, Michael and Lutolf, Matthias P},
title = {Bioengineered human colon organoids with in vivo-like cellular complexity and function},
journal = {Cell Stem Cell},
year = {2024},
volume = {31},
number = {8},
pages = {1175--1186.e7},
doi = {10.1016/j.stem.2024.05.007}
}
EUVIMED